Treatment of Meniere's disease by Multi-session Dexamethasone Injections.

Q3 Medicine
Haider Alsarhan, Sura Kadhim
{"title":"Treatment of Meniere's disease by Multi-session Dexamethasone Injections.","authors":"Haider Alsarhan,&nbsp;Sura Kadhim","doi":"10.5935/0946-5448.20220011","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Meniere's Disease (MD) is a complex and multifactorial inner ear problem characterized by episodic vertigo, unilateral sensori-neural hearing loss and tinnitus or fullness in the ear due to Endolymphatic hydrops. There are multiple treatment options available for this disease; from which cortisone therapy can be given in different routes and in different doses.</p><p><strong>Objectives: </strong>is to identify the successfulness of treatment of MD by multi-session intra-tympanic dexamethasone injection compared to the single-session method.</p><p><strong>Method: </strong>Interventional prospective study of study 70 cases of definite MD treated by 4 sessions of intra-tympanic injection weekly and compared to a control group of 66 cases of age matched patients with definite MD treated by the traditional single intra-tympanic injection. Patients In the study and the control group were observed for 6 months after the treatment for the development of any vertiginous attacks.</p><p><strong>Results: </strong>only 3 patients in the study group and 30 patients in the control group failed to respond to treatment and developed vertigo in the period of 6 months after treatment. The difference between the success rate in the two groups was statistically highly significant.</p><p><strong>Conclusion: </strong>multi-session Intra-tympanic dexamethasone injection is superior to the single injection in control of vertigo in patients with definite MD.</p>","PeriodicalId":39842,"journal":{"name":"International Tinnitus Journal","volume":"26 1","pages":"75-78"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Tinnitus Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5935/0946-5448.20220011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Meniere's Disease (MD) is a complex and multifactorial inner ear problem characterized by episodic vertigo, unilateral sensori-neural hearing loss and tinnitus or fullness in the ear due to Endolymphatic hydrops. There are multiple treatment options available for this disease; from which cortisone therapy can be given in different routes and in different doses.

Objectives: is to identify the successfulness of treatment of MD by multi-session intra-tympanic dexamethasone injection compared to the single-session method.

Method: Interventional prospective study of study 70 cases of definite MD treated by 4 sessions of intra-tympanic injection weekly and compared to a control group of 66 cases of age matched patients with definite MD treated by the traditional single intra-tympanic injection. Patients In the study and the control group were observed for 6 months after the treatment for the development of any vertiginous attacks.

Results: only 3 patients in the study group and 30 patients in the control group failed to respond to treatment and developed vertigo in the period of 6 months after treatment. The difference between the success rate in the two groups was statistically highly significant.

Conclusion: multi-session Intra-tympanic dexamethasone injection is superior to the single injection in control of vertigo in patients with definite MD.

多次地塞米松注射治疗梅尼埃病。
背景:梅尼埃氏病(MD)是一种复杂的、多因素的内耳问题,其特征是偶发性眩晕、单侧感觉神经性听力丧失和内淋巴水肿引起的耳鸣或耳内充盈。这种疾病有多种治疗方案;可的松治疗可以通过不同的途径和剂量进行。目的:比较多疗程鼓室内地塞米松注射治疗MD的成功率。方法:对每周4次鼓膜内注射治疗的70例确诊MD患者进行介入前瞻性研究,并与66例年龄匹配的传统单次鼓膜内注射治疗的确诊MD患者进行对照。研究组和对照组患者在治疗后6个月观察眩晕发作情况。结果:研究组仅有3例患者治疗无效,对照组30例患者治疗后6个月内出现眩晕。两组患者的成功率差异有统计学意义。结论:多期鼓膜内地塞米松注射控制MD患者眩晕的效果优于单次注射。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Tinnitus Journal
International Tinnitus Journal Medicine-Otorhinolaryngology
CiteScore
0.70
自引率
0.00%
发文量
11
期刊介绍: The International Tinnitus Journal is the first peer review journal to provide a forum for exchange of information of on-going basic and clinical science efforts for understanding tinnitus and its application to patient diagnosis and treatment. Subject areas to be covered range from fundamental theory to clinical applications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书